Drug Discovery Today logo Elsevier logo

Publisher: Elsevier

Related content
Volume 6, Number 10, 15 May 2001

< previous issue | all issues | next issue >

Pharmacogenomics: challenges and opportunities
pp. 495-498(4)
Authors: Peet, N.P.; Bey, P.; Parallel Track? Drug Discovery, A.

A sticky end for pathogens?
pp. 500-502(3)
Author: Owens, J.

News in brief
pp. 504-506(3)
Authors: Ramster, B.; Owens, J.; Lawrence, R.N.

pp. 507-507(1)
Author: Lawrence, R.

Molecular biology databases: today and tomorrow
pp. 509-513(5)
Authors: Ellis, L.B.M.; Attwood, T.K.

More collaboration needed between drug development and imaging communities
pp. 514-515(2)
Authors: Mankoff, D.A.; Link, J.M.; Unadkat, J.; Eary, J.F.; Krohn, K.A.

From DNA Damage and Stress Signalling to Cell Death
pp. 516-516(1)
Author: Nuttall, M.E.

Monoclonal antibody strategies to block angiogenesis
pp. 517-528(12)
Authors: Hicklin, D.J.; Witte, L.; Zhu, Z.; Liao, F.; Wu, Y.; Li, Y.; Bohlen, P.

New quinolones and the impact on resistance
pp. 529-536(8)
Authors: Dougherty, T.J.; Beaulieu, D.; Barrett, J.F.

Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery
pp. 537-544(8)
Authors: Payne, D.J.; Warren, P.V.; Holmes, D.J.; Ji, Y.; Lonsdale, J.T.

Monitor: molecules and profiles
pp. 545-547(3)
Authors: Langston, S.; Barlocco, D.; Tranter, D.

Combinatorial chemistry
pp. 547-549(3)
Author: Edwards, P.

< previous issue | all issues | next issue >


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page